Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 11, Pages 1704
Publisher
MDPI AG
Online
2019-11-02
DOI
10.3390/cancers11111704
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bazedoxifene exhibits growth suppressive activity by Targeting IL-6/GP130/STAT3 Signaling in Hepatocellular Carcinoma
- (2019) Haiyan Ma et al. CANCER SCIENCE
- ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer
- (2019) Mohamed I Saad et al. EMBO Molecular Medicine
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma
- (2019) Li Zhang et al. Molecular Cancer
- Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling
- (2019) Dongyao Wang et al. EBioMedicine
- ADAM17: An Emerging Therapeutic Target for Lung Cancer
- (2019) Saad et al. Cancers
- Non-alcoholic Steatohepatitis is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- (2018) Zobair Younossi et al. Clinical Gastroenterology and Hepatology
- Aflatoxin B 1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption
- (2018) Yu-Ju Chu et al. EUROPEAN JOURNAL OF CANCER
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
- (2018) Sven Loosen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas
- (2018) Veerabrahma Pratap Seshachalam et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- Downregulation of Epstein-Barr virus-induced gene�3 is associated with poor prognosis of hepatocellular carcinoma after curative resection
- (2018) Qingjie Song et al. Oncology Letters
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages
- (2018) Tian-yi Zhou et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- The molecular details of cytokine signalling via the JAK/STAT pathway
- (2018) Rhiannon Morris et al. PROTEIN SCIENCE
- Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma
- (2018) Buyun Ma et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway
- (2018) Ronghua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis
- (2018) Guo Tian et al. BMJ Open
- Mutations in Craniosynostosis Patients Cause Defective Interleukin-11 Receptor Maturation and Drive Craniosynostosis-like Disease in Mice
- (2018) Maria Agthe et al. Cell Reports
- Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway
- (2017) Jiwei Zhang et al. HEPATOLOGY
- The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease
- (2017) Teng-Yu Lee et al. INTERNATIONAL JOURNAL OF CANCER
- High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma
- (2017) Yu-Yun Shao et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
- (2017) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma
- (2017) Sara Torrecilla et al. JOURNAL OF HEPATOLOGY
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
- (2017) Xiao-Xiao Ding et al. Oncotarget
- Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients
- (2017) Bei-Ge Jiang et al. Oncotarget
- SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B
- (2017) Nghiem Xuan Hoan et al. Oncotarget
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73
- (2017) Hongyan Liang et al. Cancer Biomarkers
- IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice
- (2016) Juri Bergmann et al. HEPATOLOGY
- Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
- (2016) Riccardo Lencioni et al. HEPATOLOGY
- Genetic profiling of hepatocellular carcinoma using next-generation sequencing
- (2016) Kornelius Schulze et al. JOURNAL OF HEPATOLOGY
- Latest developments in precancerous lesions of hepatocellular carcinoma
- (2016) Zhao-Shan Niu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling
- (2016) Hao Zheng et al. Scientific Reports
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- STAT1 inhibits human hepatocellular carcinoma cell growth through induction of p53 and Fbxw7
- (2015) Jiayu Chen et al. Cancer Cell International
- LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway
- (2015) Qin Luo et al. CARCINOGENESIS
- The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
- (2015) Christoph Garbers et al. CURRENT OPINION IN IMMUNOLOGY
- The biology of interleukin-27 reveals unique pro- and anti-inflammatory functions in immunity
- (2015) Samadhi Aparicio-Siegmund et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Mutations leading to constitutive active gp130/JAK1/STAT3 pathway
- (2015) Camilla Pilati et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology
- (2015) Heike M. Hermanns CYTOKINE & GROWTH FACTOR REVIEWS
- Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study
- (2015) Tsunenobu Sato et al. Hepatology International
- SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma
- (2015) Xin Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A gp130–Src–YAP module links inflammation to epithelial regeneration
- (2015) Koji Taniguchi et al. NATURE
- Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model
- (2015) M Hatting et al. Cell Death & Disease
- Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
- (2015) Shuqun Yang et al. Oncotarget
- Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules
- (2015) Qin Luo et al. Oncotarget
- The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases
- (2014) Christoph Garbers et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma
- (2014) Ji-hang Yuan et al. CANCER CELL
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- Reconstruction of an active SOCS3-based E3 ubiquitin ligase complexin vitro: identification of the active components and JAK2 and gp130 as substrates
- (2014) Nadia J. Kershaw et al. GROWTH FACTORS
- Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis
- (2014) Jean Charles Nault et al. HEPATOLOGY
- HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV
- (2014) Fasiha Kanwal et al. HEPATOLOGY
- Inhibition of IL-6 family cytokines by SOCS3
- (2014) Jeffrey J. Babon et al. SEMINARS IN IMMUNOLOGY
- Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma
- (2014) Karine Poussin et al. OncoImmunology
- Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
- (2013) S. Schlesinger et al. ANNALS OF ONCOLOGY
- Steatohepatitic Hepatocellular Carcinoma, a Morphologic Indicator of Associated Metabolic Risk Factors: A Study From India
- (2013) Deepali Jain et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Interleukin-6 and interleukin-11: same same but different
- (2013) Christoph Garbers et al. BIOLOGICAL CHEMISTRY
- Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro
- (2013) George S. Wilson et al. CANCER LETTERS
- Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
- (2013) Z. Kan et al. GENOME RESEARCH
- Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients
- (2013) Junji Shibahara et al. HISTOPATHOLOGY
- Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits
- (2013) Jens U. Marquardt et al. JOURNAL OF HEPATOLOGY
- SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibition
- (2013) Nadia J Kershaw et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- STAT1 negatively regulates hepatocellular carcinoma cell proliferation
- (2013) GUOFU CHEN et al. ONCOLOGY REPORTS
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases
- (2013) Ricardo C. Ferreira et al. PLoS Genetics
- Mutations in the interleukin receptorIL11RAcause autosomal recessive Crouzon-like craniosynostosis
- (2013) Katharina Keupp et al. Molecular Genetics & Genomic Medicine
- Plasticity and cross-talk of Interleukin 6-type cytokines
- (2012) Christoph Garbers et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Qin WANG et al. Journal of Digestive Diseases
- Model-driven experimental analysis of the function of SHP-2 in IL-6-induced Jak/STAT signaling
- (2012) Anna Dittrich et al. Molecular BioSystems
- Inactivation of IL11 Signaling Causes Craniosynostosis, Delayed Tooth Eruption, and Supernumerary Teeth
- (2011) Pekka Nieminen et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Liver precancerous lesions and hepatocellular carcinoma: The histology report
- (2011) Massimo Roncalli et al. DIGESTIVE AND LIVER DISEASE
- Interleukin-6 signalling: More than Jaks and STATs
- (2011) René Eulenfeld et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling
- (2011) Jin-fang Zhang et al. HEPATOLOGY
- The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis
- (2011) Marcela Salomao et al. HUMAN PATHOLOGY
- A clinicopathological model to predict bone metastasis in hepatocellular carcinoma
- (2011) Zuo-Lin Xiang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
- (2011) Camilla Pilati et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma
- (2011) Zuo-Lin Xiang et al. MOLECULAR BIOLOGY REPORTS
- The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling
- (2011) Daniela Ungureanu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Potential Prognostic Biomarkers for Bone Metastasis from Hepatocellular Carcinoma
- (2011) Z.-L. Xiang et al. ONCOLOGIST
- Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation
- (2010) Guobin He et al. CANCER CELL
- The Etiology of Hepatocellular Carcinoma and Consequences for Treatment
- (2010) A. J. Sanyal et al. ONCOLOGIST
- Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array
- (2009) Yukiyasu Okamura et al. CANCER LETTERS
- Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis
- (2009) Valérie Paradis et al. HEPATOLOGY
- Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis
- (2009) Sara Raimondi et al. JOURNAL OF HEPATOLOGY
- Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
- (2009) Puneeta Tandon et al. LIVER INTERNATIONAL
- Chromosomal instability, telomere shortening and inactivation of p21WAF1/CIP1 in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis
- (2009) Yoon Hee Lee et al. MODERN PATHOLOGY
- Mutational analysis of JAK1 gene in human hepatocellular carcinoma
- (2009) H. Xie et al. NEOPLASMA
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia
- (2008) HEPATOLOGY
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
- (2008) Sandra Rebouissou et al. NATURE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More